Peer-reviewedCC BY-NCLupus science & medicine20 Oct 2026

Fatigue outcomes with anifrolumab in low-disease-activity SLE: DNA damage in plasmacytoid dendritic cells as a candidate biomarker for responders.

Eitaro Yoshida¹
Taiga Kuga²
Yusuke Yanagimoto¹
Emi Nakanishi¹
Ayako Makiyama¹
Goh Murayama¹
Kentaro Minowa¹
Makio Kusaoi¹
Ken Yamaji¹
Naoto Tamura¹

¹Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.
²Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan [email protected].

Unexpected detrimental role of plasmacytoid dendritic cells during viral infections of the lungs
Marc Dalod, Elena Tomasello
Médecine/Sciences29 Oct 2026Peer-reviewedCC BY 4.0Full textImmunology Infectious diseaseHAL
Case Report: Chronic myelomonocytic leukemia with mature plasmacytoid dendritic cell proliferation initially classified as MDS-IB2
Junhong Chen, Juan Liu, Yanying Ren
Frontiers in Oncology22 Oct 2026Peer-reviewedCC BY 4.0Full textOncologyCrossref
Integrated Transcriptomic Analysis Identifies ENO3 as a Candidate Lactate Metabolism‐Associated Biomarker in Colorectal Cancer Metastasis
Jiahao Qian, Miaomiao Wang, Jiaqi Liu +1
Cancer reports (Hoboken, N.J.)1 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Minute-Scale Sleep-Onset HRV as a Candidate Risk-Stratification Biomarker for Diabetic Retinopathy: An Exploratory Pilot Study
Yi-Ting Cheng, Yu-Cheng Lin, Yu-Ting Ho +2
Diagnostics (Basel, Switzerland)1 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Single-cell, spatial, and machine learning analyses identify ANKIB1 as an oligodendrocyte-anchored palmitoylation-associated candidate biomarker of Alzheimer’s disease
Jinshu Liang, Zongtang Xu, Ziting Zhu +7
Translational Psychiatry8 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textPhysiologyCrossref

Cite

BibTeX

@article{yoshida2026fatigue,
  title = {{Fatigue outcomes with anifrolumab in low-disease-activity SLE: DNA damage in plasmacytoid dendritic cells as a candidate biomarker for responders.}},
  author = {Eitaro Yoshida and Taiga Kuga and Yusuke Yanagimoto and Emi Nakanishi and Ayako Makiyama and Goh Murayama and Kentaro Minowa and Makio Kusaoi and Ken Yamaji and Naoto Tamura},
  journal = {Lupus science \& medicine},
  year = {2026},
  month = oct,
  doi = {10.1136/lupus-2026-002234},
  url = {https://europepmc.org/article/MED/42901716},
  note = {CC BY-NC},
}

RIS

TY  - JOUR
TI  - Fatigue outcomes with anifrolumab in low-disease-activity SLE: DNA damage in plasmacytoid dendritic cells as a candidate biomarker for responders.
AU  - Eitaro Yoshida
AU  - Taiga Kuga
AU  - Yusuke Yanagimoto
AU  - Emi Nakanishi
AU  - Ayako Makiyama
AU  - Goh Murayama
AU  - Kentaro Minowa
AU  - Makio Kusaoi
AU  - Ken Yamaji
AU  - Naoto Tamura
PY  - 2026
DA  - 2026/10/20
JO  - Lupus science & medicine
DO  - 10.1136/lupus-2026-002234
UR  - https://europepmc.org/article/MED/42901716
SN  - 2053-8790
ER  -

Related

Cite